carbidopa

[kahr-bĭ-do´pah] an inhibitor of the decarboxylation of levodopa" >levodopa in peripheral tissues; it does not cross the blood-brain barrier and is used in combination with levodopa to control the symptoms of parkinson's disease. In the presence of carbidopa, levodopa enters the brain in larger quantities, thus avoiding the need for excessively high doses of levodopa.

car·bi·do·pa

(kar'bi-dō'pă), A dopa decarboxylase inhibitor that does not enter the brain used in conjunction with levodopa in the treatment of Parkinson disease to reduce L-dopa dosage and mitigate side effects.

carbidopa

(kär′bĭ-dō′pə)n. A drug, C₁₀H₁₄N₂O₄, that increases the availability of L-dopa to the brain and is administered with L-dopa to treat Parkinson's disease.

car·bi·do·pa

(kahr'bi-dō'pă) A dopa decarboxylase inhibitor that does not enter the brain used in conjunction with levodopa in the treatment of parkinsonism to reduce L-dopa dosage and mitigate side effects.

carbidopa

A drug that prevents the breakdown of the drug levodopa in the body and thus enhances its action in PARKINSON'S DISEASE. See also BENSERAZIDE. A brand name is Sinemet.

单词	carbidopa
释义	carbidopa car·bi·do·pa C5101350 (kär′bĭ-dō′pə)n. A drug, C₁₀H₁₄N₂O₄, that increases the availability of L-dopa to the brain and is administered with L-dopa to treat Parkinson's disease. [Alteration of carbo- + dopa.] Translations EncyclopediaSeelevodopa carbidopa carbidopa [kahr-bĭ-do´pah] an inhibitor of the decarboxylation of levodopa" >levodopa in peripheral tissues; it does not cross the blood-brain barrier and is used in combination with levodopa to control the symptoms of parkinson's disease. In the presence of carbidopa, levodopa enters the brain in larger quantities, thus avoiding the need for excessively high doses of levodopa. car·bi·do·pa (kar'bi-dō'pă), A dopa decarboxylase inhibitor that does not enter the brain used in conjunction with levodopa in the treatment of Parkinson disease to reduce L-dopa dosage and mitigate side effects. carbidopa (kär′bĭ-dō′pə)n. A drug, C₁₀H₁₄N₂O₄, that increases the availability of L-dopa to the brain and is administered with L-dopa to treat Parkinson's disease. car·bi·do·pa (kahr'bi-dō'pă) A dopa decarboxylase inhibitor that does not enter the brain used in conjunction with levodopa in the treatment of parkinsonism to reduce L-dopa dosage and mitigate side effects. carbidopa A drug that prevents the breakdown of the drug levodopa in the body and thus enhances its action in PARKINSON'S DISEASE. See also BENSERAZIDE. A brand name is Sinemet.
随便看	american numismatic association american numismatic association certification service american numismatic society american numismatic society museum notes american nursery & landscape association american nurses assocation american nurses association american nurses' association american nurses association\california american nurses association california american nurses association network american nurses association-political action committee american nurses association steering committee on databases american nurses credentialing center american nurses foundation american nursing assistants association american nursing association american nursing informatics association american nutmeg american nutraceutical association american nutritional medical association american nutrition, inc. american nyckelharpa association americano american obesity association